Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-18-061046
Filing Date
2018-12-04
Accepted
2018-12-04 18:54:29
Documents
1
Period of Report
2018-12-03

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2910
  Complete submission text file 0001209191-18-061046.txt   4436
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Issuer) CIK: 0001610618 (see all company filings)

EIN.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O CIDARA THERAPEUTICS, INC. 6310 NANCY RIDGE DR, SUITE 101 SAN DIEGO CA 92121
Business Address
Oien Jessica (Reporting) CIK: 0001760712 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36912 | Film No.: 181218219